Biochemical characterization of MIF nuclease with a FRET-based quantitative 3' nuclease assay

Ruikang Zhao1, Pan He1, Yike Fang1

  • 1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.

Insights

Macrophage Migration Inhibitory Factor (MIF) is a nuclease and cancer target. A new assay characterizes MIF activity, identifying essential cofactors and modulators, aiding anticancer drug development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Macrophage Migration Inhibitory Factor (MIF) is implicated in DNA replication and elevated in various cancers.
  • MIF's role as a nuclease presents a potential therapeutic target for cancer treatment.

Purpose of the Study:

  • To develop a quantitative assay for measuring MIF nuclease activity.
  • To characterize the enzymatic properties of MIF, including cofactor requirements and modulators.
  • To establish a platform for high-throughput screening of MIF inhibitors for anticancer drug development.

Main Methods:

  • Development of a Förster Resonance Energy Transfer (FRET)-based quantitative nuclease assay.
  • Assay designed to specifically measure the cleavage of 3' overhangs by MIF.
  • Enzymatic characterization of MIF activity under varying conditions.

Main Results:

  • Identification of Mg2+ as an essential cofactor for MIF activity, with optimal concentration at 10 mM.
  • Discovery of a dual modulatory role of glucose on MIF enzymatic function.
  • Demonstration of the assay's robustness for enzymatic characterization and inhibitor screening.

Conclusions:

  • The developed FRET assay provides a robust method for quantifying MIF nuclease activity.
  • Understanding MIF's enzymatic properties and cofactor requirements is crucial for drug development.
  • This platform facilitates the discovery and advancement of novel anticancer therapeutics targeting MIF.

Related Concept Videos